Article Versions Notes

Barutello G, Rolih V, Arigoni M, Tarone L, Conti L, Quaglino E, Buracco P, Cavallo F, Riccardo F. Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy. International Journal of Molecular Sciences. 2018; 19(3):799. https://doi.org/10.3390/ijms19030799

Barutello, Giuseppina, Valeria Rolih, Maddalena Arigoni, Lidia Tarone, Laura Conti, Elena Quaglino, Paolo Buracco, Federica Cavallo, and Federica Riccardo. 2018. "Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy" International Journal of Molecular Sciences 19, no. 3: 799. https://doi.org/10.3390/ijms19030799

Barutello, G., Rolih, V., Arigoni, M., Tarone, L., Conti, L., Quaglino, E., Buracco, P., Cavallo, F., & Riccardo, F. (2018). Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy. International Journal of Molecular Sciences, 19(3), 799. https://doi.org/10.3390/ijms19030799